Skip to main content
Clinical Trials/JPRN-UMIN000011851
JPRN-UMIN000011851Completed未知

The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study). - The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization.

ippon Medical School, Chiba-Hokusoh Hospital, Division of Endocrinology, Department of Medicine0 sites40 target enrollmentStarted: September 24, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The subjects were excluded, if they were treated with insulin, DPP-4I or GLP-1 receptor agonist, have a history or evidence of liver or endocrine disease, recent myocardial infarction, cerebral vascular disease, heart failure, infectious disease, pregnancy or any carcinoma.

Investigators

Sponsor
ippon Medical School, Chiba-Hokusoh Hospital, Division of Endocrinology, Department of Medicine

Similar Trials